{"id":"https://openalex.org/W2553349262","doi":"https://doi.org/10.1182/blood.v110.11.1451.1451","title":"A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.","display_name":"A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.","publication_year":2007,"publication_date":"2007-11-16","ids":{"openalex":"https://openalex.org/W2553349262","doi":"https://doi.org/10.1182/blood.v110.11.1451.1451","mag":"2553349262"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v110.11.1451.1451","doi":"https://doi.org/10.1182/blood.v110.11.1451.1451","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.1451.1451","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009773917","display_name":"Richard A. Walgren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Walgren","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103682464","display_name":"Crystal Dao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Crystal Dao","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013146985","display_name":"Frederieke Kreisel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frederieke Kreisel","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105528827","display_name":"Peter Westervelt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Westervelt","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103189440","display_name":"Camille N. Abboud","orcid":"https://orcid.org/0000-0002-5469-8534","observed_orcids":["https://orcid.org/0000-0002-5469-8534"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Camille Abboud","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056921013","display_name":"Timothy Aaron Graubert","orcid":"https://orcid.org/0000-0002-7710-1171","observed_orcids":["https://orcid.org/0000-0002-7710-1171"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Graubert","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108089232","display_name":"Amanda F. Cashen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Cashen","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101423957","display_name":"Geoffrey L. Uy","orcid":"https://orcid.org/0000-0002-7809-0996","observed_orcids":["https://orcid.org/0000-0002-7809-0996"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Uy","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008654358","display_name":"Feng Gao","orcid":"https://orcid.org/0000-0002-1425-1623","observed_orcids":["https://orcid.org/0000-0002-1425-1623"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Feng Gao","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065066309","display_name":"John F. DiPersio","orcid":"https://orcid.org/0000-0002-0429-3133","observed_orcids":["https://orcid.org/0000-0002-0429-3133"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John DiPersio","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026151069","display_name":"Ravi Vij","orcid":"https://orcid.org/0000-0001-8795-3610","observed_orcids":["https://orcid.org/0000-0001-8795-3610"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi Vij","raw_affiliation_strings":["Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I204465549"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2115,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.64086639,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"110","issue":"11","first_page":"1451","last_page":"1451"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.8650000095367432},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9430000185966492},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.902999997138977},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8999999761581421},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.8669999837875366},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.843999981880188},{"id":"https://openalex.org/keywords/hematologic-improvement","display_name":"hematologic improvement","score":0.6570000052452087},{"id":"https://openalex.org/keywords/cytogenetic-response","display_name":"cytogenetic response","score":0.8420000076293945},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7239999771118164},{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.7120000123977661},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.6980000138282776},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.48399999737739563},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.621999979019165},{"id":"https://openalex.org/keywords/fab-classification","display_name":"FAB classification","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8433206081390381},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.7375860810279846},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6713885068893433},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.6268162131309509},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5542623996734619},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5079496502876282},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5030221343040466},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4931716322898865},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4871542155742645},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.44524073600769043},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42434537410736084},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.42286115884780884},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.41466251015663147},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.30851608514785767},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.10891416668891907},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v110.11.1451.1451","doi":"https://doi.org/10.1182/blood.v110.11.1451.1451","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.1451.1451","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2590254040","https://openalex.org/W2564506912","https://openalex.org/W2079254093","https://openalex.org/W2583162692","https://openalex.org/W2552786607","https://openalex.org/W2095394793","https://openalex.org/W2161234867","https://openalex.org/W2021523266","https://openalex.org/W2414752671","https://openalex.org/W2588146609"],"abstract_inverted_index":{"Abstract":[0],"Rationale:":[1],"5-Azacytidine":[2],"(Aza),":[3],"a":[4,22,35,66,107,156,167,189,211,252,265,284,352,377,386,393,400],"DNA":[5],"hypomethylating":[6],"agent,":[7],"has":[8],"now":[9],"been":[10],"shown":[11],"in":[12,45,60,122,472,499,544],"2":[13,380,409],"clinical":[14],"trials":[15],"involving":[16],"high-risk":[17],"MDS":[18],"patients":[19,123,185,205,339],"to":[20,73,187,214,242,273,292,305,359,406,420,437,442,451,534],"provide":[21],"survival":[23],"benefit":[24],"over":[25],"supportive/conventional":[26],"care":[27],"regimens.":[28],"While":[29],"one":[30],"phase":[31,117],"II":[32,118],"study":[33,119,434,452,533],"used":[34],"continuous":[36],"7-day":[37],"IV":[38,89,102,159],"infusion,":[39,109],"Aza":[40,63,103,121,145,151,543],"was":[41,171,408],"administered":[42],"subcutaneously":[43],"(SQ)":[44],"most":[46],"pre-approval":[47],"studies.":[48],"However,":[49,379],"injection":[50],"site":[51],"reactions":[52],"are":[53,91,325],"not":[54,513],"uncommon":[55],"with":[56,124,251,264,283,348],"SQ":[57],"dosing,":[58],"especially":[59],"thrombocytopenic":[61],"patients.":[62],"given":[64,105,154],"as":[65,106,155,330],"short":[67,88,108,523,541],"intravenous":[68],"(IV)":[69],"infusion":[70,90,160],"is":[71,80,299,522,529],"anticipated":[72],"be":[74],"efficacious":[75],"from":[76,297],"pharmacokinetic":[77],"profiling":[78],"and":[79,95,227,232,244,280,320,323,335,428,444,460,466,491,506,538],"FDA":[81],"approved,":[82],"but":[83,509],"prospective":[84,532],"efficacy":[85,100,537],"data":[86,345],"for":[87,193,524],"lacking.":[92],"Study":[93,218],"aim":[94],"design:":[96],"To":[97],"determine":[98],"the":[99,181,223,236,363,530,545],"of":[101,120,150,166,197,203,222,238,254,258,268,277,287,313,354,362,373,382,426,526,540,547],"when":[104],"we":[110],"have":[111,207,262,367,375,431,497,512],"undertaken":[112],"an":[113,194],"open-label,":[114],"single-arm,":[115],"single-center":[116],"MDS,":[125],"either":[126],"de":[127],"novo":[128],"or":[129,146,478],"secondary,":[130],"defined":[131],"by":[132,173,327],"FAB":[133,309],"classification.":[134],"Previously":[135],"treated":[136],"subjects":[137,261,311,324,349,365,384,412],"were":[138,191,449],"ineligible":[139],"if":[140],"they":[141],"had":[142,340,392,399],"already":[143],"received":[144],"decitabine.":[147],"Treatment":[148],"consisted":[149,276],"75":[152,182],"mg/m2":[153,183],"20":[157],"minute":[158],"once":[161],"daily":[162],"on":[163,216,414,433,517,536],"Days":[164],"1\u20135":[165],"28-day":[168],"cycle.":[169],"Response":[170],"evaluated":[172],"IWG":[174],"2000":[175],"criteria.":[176],"After":[177,200],"two":[178],"cycles":[179,202,356,372],"at":[180,209,369],"dose,":[184],"failing":[186],"achieve":[188],"CR":[190],"eligible":[192],"increased":[195],"dose":[196,507],"100":[198],"mg/m2.":[199],"6":[201,281],"therapy,":[204],"must":[206],"demonstrated":[208],"least":[210,370],"hematologic":[212,461,480,510],"improvement":[213],"continue":[215],"study.":[217,518],"endpoints":[219,234],"include":[220,457],"determination":[221],"complete":[224],"response":[225,229,407],"(CR)":[226],"partial":[228],"(PR)":[230],"rates,":[231],"secondary":[233],"examined":[235],"rates":[237],"hematological":[239],"improvement,":[240],"time":[241,296,405],"progression,":[243],"cytogenetic":[245],"response.":[246,403],"Results:":[247],"Accrual":[248],"began":[249],"8/17/06":[250],"target":[253],"21":[255],"subjects.":[256,474],"As":[257],"7/31/07,":[259],"15":[260],"accrued":[263],"median":[266,285,295],"follow-up":[267,521],"77":[269],"days":[270,301,304],"(range":[271,290,302,357],"4":[272,306,314,333,371,429,479,504],"246).":[274],"Subjects":[275],"9":[278,316],"males":[279],"females":[282],"age":[286],"69.6":[288],"yr":[289],"53":[291],"82).":[293],"The":[294,344],"diagnosis":[298],"213":[300],"0":[303],"yr).":[307],"By":[308],"criteria,":[310],"consist":[312],"RA,":[315],"RAEB,":[317],"1":[318,321,331,358,389,416,439],"RAEB-t,":[319],"CMML,":[322],"categorized":[326],"IPSS":[328],"risk":[329],"Low,":[332],"Int-1,":[334],"10":[336],"Int-2.":[337],"Two":[338],"therapy":[341,374],"related":[342],"MDS.":[343,548],"remain":[346,413],"preliminary":[347],"having":[350],"completed":[351,368],"mean":[353],"3":[355,477],"6).":[360],"None":[361],"5":[364,473],"who":[366],"achieved":[376,385],"CR.":[378],"(40%)":[381],"these":[383],"PR.":[387],"Additionally,":[388],"(20%)":[390],"patient":[391,417],"major":[394],"erythroid":[395,402],"response,":[396],"while":[397],"another":[398],"minor":[401],"Median":[404],"months.":[410],"Ten":[411],"study,":[415],"withdrew":[418],"due":[419,436,441],"progressive":[421],"disease":[422],"(in":[423],"first":[424,531],"week":[425],"therapy),":[427],"deaths":[430,448],"occurred":[432,471],"(2":[435],"sepsis,":[438],"each":[440,470],"pneumonia":[443],"acute":[445],"MI).":[446],"No":[447],"attributed":[450],"drug.":[453],"Common":[454],"adverse":[455],"events":[456],"nausea,":[458],"emesis,":[459],"toxicities.":[462],"Grade":[463],"2\u20133":[464,468],"nausea":[465],"grade":[467,476],"emesis":[469],"Observed":[475],"toxicities":[481,496,511],"included:":[482],"anemia":[483],"(n=7),":[484,490],"thrombocytopenia":[485],"(n=4),":[486],"leukopenia":[487],"(n=3),":[488],"neutropenia":[489,493],"febrile":[492],"(n=1).":[494],"Hematologic":[495],"resulted":[498],"transient":[500],"treatment":[501,516,546],"delays":[502],"(<":[503],"weeks)":[505],"reduction,":[508],"prevented":[514],"subsequent":[515],"Conclusions:":[519],"Although":[520],"assessment":[525],"efficacy,":[527],"this":[528],"report":[535],"toxicity":[539],"infusional":[542]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-11-30T00:00:00"}